Skip to main content
logo
Aspen Neuroscience, Inc. (ASPE)
NASDAQ: ASPE · Real-Time Price · USD
11.58
-1.19 (-9.29%)
At close: Nov 5, 2026, 4:00 PM EST
11.99
+0.42 (3.59%)
After-hours: Nov 5, 2026, 4:15 PM EST

Aspen Neuroscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Income
-66.84-62.06-48.56
Depreciation & Amortization
4.133.963.51
Loss (Gain) From Sale of Investments
-0.84-0.05-1.96
Stock-Based Compensation
3.782.522.71
Other Operating Activities
2.814.55-0.5
Change in Accounts Payable
2.91.79-0.3
Change in Other Net Operating Assets
-2.67-3.550.94
Operating Cash Flow
-56.73-52.85-44.16
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Capital Expenditures
-9.78-9.69-2.58
Investment in Securities
-36.413.8928.22
Other Investing Activities
---5
Investing Cash Flow
-46.174.220.63

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Issuance of Common Stock
0.250.170.47
Other Financing Activities
-1.09-0.27-0.01
Financing Cash Flow
114.78115.530.46

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Cash Flow
11.8866.88-23.07

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Free Cash Flow
-66.51-62.54-46.75
Free Cash Flow Growth
---
Free Cash Flow Per Share
-6.26-6.06-5.05
Levered Free Cash Flow
--39.94-
Unlevered Free Cash Flow
--39.94-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Change in Working Capital
0.23-1.770.63
SEC Filings: 10-K · 10-Q